Geoffrey Allan Net Worth

The estimated Net Worth of Geoffrey Allan is at least $84.9 million dollars as of 21 June 2007. Geoffrey Allan owns over 165,000 units of Insmed Inc stock worth over $84,871,921 and over the last 20 years Geoffrey sold INSM stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Geoffrey Allan INSM stock SEC Form 4 insiders trading

Geoffrey has made over 2 trades of the Insmed Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently Geoffrey bought 165,000 units of INSM stock worth $118,800 on 21 June 2007.

The largest trade Geoffrey's ever made was buying 165,000 units of Insmed Inc stock on 21 June 2007 worth over $118,800. On average, Geoffrey trades about 50,500 units every 180 days since 2005. As of 21 June 2007 Geoffrey still owns at least 1,166,464 units of Insmed Inc stock.

You can see the complete history of Geoffrey Allan stock trades at the bottom of the page.

What's Geoffrey Allan's mailing address?

Geoffrey's mailing address filed with the SEC is C/O INSMED INCORPORATED, PO BOX 2400, GLEN ALLEN, VA, 23058-2400.

Insiders trading at Insmed Inc

Over the last 21 years, insiders at Insmed Inc have traded over $46,121,705 worth of Insmed Inc stock and bought 1,080,212 units worth $8,226,993 . The most active insiders traders include Llc Fmr, William Lewis et Dennis M Lanfear. On average, Insmed Inc executives and independent directors trade stock every 38 days with the average trade being worth of $2,452,158. The most recent stock trade was executed by Orlov S Nicole Schaeffer on 10 September 2024, trading 37,575 units of INSM stock currently worth $407,689.

What does Insmed Inc do?

insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.

Complete history of Geoffrey Allan stock trades at Insmed Inc

Insmed Inc executives and stock owners

Insmed Inc executives and other stock owners filed with the SEC include:

• William Lewis,
  Chairman of the Board, President, Chief Executive Officer
• Roger Adsett,
  Chief Operating Officer
• Christine Pellizzari,
  Chief Legal Officer
• S. Nicole Schaeffer,
  Chief People Strategy Officer
• William H. Lewis J.D., M.B.A.,
  Pres, CEO & Chairman
• Dr. Martina Flammer M.B.A., M.D.,
  Chief Medical Officer
• John Goll,
  Chief Accounting Officer
• Roger Adsett,
  Chief Operating Officer
• Christine A. Pellizzari J.D.,
  Consultant
• Sara M. Bonstein MBA,
  Chief Financial Officer
• John Goll III,
  Sr. VP & Chief Accounting Officer
• David Brennan,
  Lead Independent Director
• Alfred Altomari,
  Independent Director
• Steinar Engelsen,
  Independent Director
• David McGirr,
  Independent Director
• Melvin Sharoky,
  Independent Director
• Leo Lee,
  Independent Director
• Elizabeth Anderson,
  Independent Director
• Clarissa Desjardins,
  Independent Director
• Carol Schafer,
  Director
• Martina Flammer,
  Chief Medical Officer
• John Soriano,
  Chief Compliance Officer
• Sara Bonstein,
  Chief Financial Officer
• S. Nicole Schaeffer,
  Chief People Strategy Officer
• Mandy Fahey,
  Sr. Director of Corp. Communications
• Michael Alexander Smith,
  Sr. VP & Gen. Counsel
• John D. Soriano J.D.,
  Chief Compliance Officer
• Eleanor Barisser,
  Associate Director of Investor Relations
• Paolo Tombesi,
  Chief Financial Officer
• Paul Streck,
  Chief Medical Officer
• Eugene Jeffrey Sullivan,
  Chief Medical Officer
• Myrtle S Potter,
  Director
• Donald J Jr Hayden,
  Director
• Geoffrey Allan,
  President, CEO and Chairman
• Stephen C. Glover,
  President Follow-on Biologics
• Doug Farrar,
  Vice President, ITP
• Michael Duncan,
  Principal Financial Officer
• Thomas A Keuer,
  VP, ITP (Subsidiary)
• Philip J Young,
  Chief Business Officer and EVP
• Ronald D Gunn,
  Executive Vice President
• Mark Quigley,
  Vice President, Quality
• Randall W Whitcomb,
  Director
• Peggy Berry,
  Vice President, Regulatory
• Renu Gupta,
  Chief Medical Officer
• Richard S Kollender,
  Director
• Matthew Pauls,
  Chief Commercial Officer
• Llc Fmr,
  10% owner
• Andrea Holtzman Drucker,
  Senior V.P., General Counsel
• Nicholas A. Jr. La Bella,
  Chief Scientific Officer
• Kenneth G Condon,
  Director
• Kevin P Tully,
  Executive VP & CFO
• Timothy Whitten,
  President & CEO
• Graham K Crooke,
  Director
• Nicholas Lee Gurreri,
  Senior VP, Commercial Ops
• Dennis M Lanfear,
  Director
• John Drayton Wise,
  Chief Commercial Officer
• Michael Alexander Smith,
  Chief Legal Officer